Cargando…

Clinical features of biliary tract cancer in Japanese individuals with Lynch syndrome

BACKGROUND: Biliary tract cancer (BTC) is a Lynch syndrome (LS)-associated cancer with a high mortality rate. This study aimed to clarify the clinical features of BTC in individuals with LS and to discuss its management. METHODS: We obtained data from genetically verified Japanese individuals with L...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanaya, Nobuhiko, Aoki, Hideki, Morito, Toshiaki, Taniguchi, Fumitaka, Shigeyasu, Kunitoshi, Tamura, Chieko, Sugano, Kokichi, Akagi, Kiwamu, Ishida, Hideyuki, Tanakaya, Kohji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660066/
https://www.ncbi.nlm.nih.gov/pubmed/36388648
http://dx.doi.org/10.21037/jgo-22-165
_version_ 1784830343091585024
author Kanaya, Nobuhiko
Aoki, Hideki
Morito, Toshiaki
Taniguchi, Fumitaka
Shigeyasu, Kunitoshi
Tamura, Chieko
Sugano, Kokichi
Akagi, Kiwamu
Ishida, Hideyuki
Tanakaya, Kohji
author_facet Kanaya, Nobuhiko
Aoki, Hideki
Morito, Toshiaki
Taniguchi, Fumitaka
Shigeyasu, Kunitoshi
Tamura, Chieko
Sugano, Kokichi
Akagi, Kiwamu
Ishida, Hideyuki
Tanakaya, Kohji
author_sort Kanaya, Nobuhiko
collection PubMed
description BACKGROUND: Biliary tract cancer (BTC) is a Lynch syndrome (LS)-associated cancer with a high mortality rate. This study aimed to clarify the clinical features of BTC in individuals with LS and to discuss its management. METHODS: We obtained data from genetically verified Japanese individuals with LS who were diagnosed at a single institution, between January 2003 and April 2021. Moreover, 21 individuals with sporadic BTC (n=15) and LS associated BTC (n=6) underwent microsatellite instability (MSI) testing. RESULTS: Among 92 individuals with LS, 6 individuals with MLH1 variants developed BTCs (10 lesions, male/female, 2:1). The median age at diagnosis of initial BTC was 69 years (range, 34–78 years). Histological examination revealed a predominance of differentiated adenocarcinoma (89%). Then, 2 individuals had multiple BTCs. All available 7 BTC lesions showed high-frequency of microsatellite instability (MSI-H). MLH1 carriers showed a 7.2% cumulative risk of BTC development at an age of 70 years. Five of the six individuals died of BTC. CONCLUSIONS: MSI analysis could facilitate LS identification in individuals with BTC. Surveillance for BTC should be considered for MLH1 carriers in Japan.
format Online
Article
Text
id pubmed-9660066
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-96600662022-11-15 Clinical features of biliary tract cancer in Japanese individuals with Lynch syndrome Kanaya, Nobuhiko Aoki, Hideki Morito, Toshiaki Taniguchi, Fumitaka Shigeyasu, Kunitoshi Tamura, Chieko Sugano, Kokichi Akagi, Kiwamu Ishida, Hideyuki Tanakaya, Kohji J Gastrointest Oncol Original Article BACKGROUND: Biliary tract cancer (BTC) is a Lynch syndrome (LS)-associated cancer with a high mortality rate. This study aimed to clarify the clinical features of BTC in individuals with LS and to discuss its management. METHODS: We obtained data from genetically verified Japanese individuals with LS who were diagnosed at a single institution, between January 2003 and April 2021. Moreover, 21 individuals with sporadic BTC (n=15) and LS associated BTC (n=6) underwent microsatellite instability (MSI) testing. RESULTS: Among 92 individuals with LS, 6 individuals with MLH1 variants developed BTCs (10 lesions, male/female, 2:1). The median age at diagnosis of initial BTC was 69 years (range, 34–78 years). Histological examination revealed a predominance of differentiated adenocarcinoma (89%). Then, 2 individuals had multiple BTCs. All available 7 BTC lesions showed high-frequency of microsatellite instability (MSI-H). MLH1 carriers showed a 7.2% cumulative risk of BTC development at an age of 70 years. Five of the six individuals died of BTC. CONCLUSIONS: MSI analysis could facilitate LS identification in individuals with BTC. Surveillance for BTC should be considered for MLH1 carriers in Japan. AME Publishing Company 2022-10 /pmc/articles/PMC9660066/ /pubmed/36388648 http://dx.doi.org/10.21037/jgo-22-165 Text en 2022 Journal of Gastrointestinal Oncology. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Kanaya, Nobuhiko
Aoki, Hideki
Morito, Toshiaki
Taniguchi, Fumitaka
Shigeyasu, Kunitoshi
Tamura, Chieko
Sugano, Kokichi
Akagi, Kiwamu
Ishida, Hideyuki
Tanakaya, Kohji
Clinical features of biliary tract cancer in Japanese individuals with Lynch syndrome
title Clinical features of biliary tract cancer in Japanese individuals with Lynch syndrome
title_full Clinical features of biliary tract cancer in Japanese individuals with Lynch syndrome
title_fullStr Clinical features of biliary tract cancer in Japanese individuals with Lynch syndrome
title_full_unstemmed Clinical features of biliary tract cancer in Japanese individuals with Lynch syndrome
title_short Clinical features of biliary tract cancer in Japanese individuals with Lynch syndrome
title_sort clinical features of biliary tract cancer in japanese individuals with lynch syndrome
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660066/
https://www.ncbi.nlm.nih.gov/pubmed/36388648
http://dx.doi.org/10.21037/jgo-22-165
work_keys_str_mv AT kanayanobuhiko clinicalfeaturesofbiliarytractcancerinjapaneseindividualswithlynchsyndrome
AT aokihideki clinicalfeaturesofbiliarytractcancerinjapaneseindividualswithlynchsyndrome
AT moritotoshiaki clinicalfeaturesofbiliarytractcancerinjapaneseindividualswithlynchsyndrome
AT taniguchifumitaka clinicalfeaturesofbiliarytractcancerinjapaneseindividualswithlynchsyndrome
AT shigeyasukunitoshi clinicalfeaturesofbiliarytractcancerinjapaneseindividualswithlynchsyndrome
AT tamurachieko clinicalfeaturesofbiliarytractcancerinjapaneseindividualswithlynchsyndrome
AT suganokokichi clinicalfeaturesofbiliarytractcancerinjapaneseindividualswithlynchsyndrome
AT akagikiwamu clinicalfeaturesofbiliarytractcancerinjapaneseindividualswithlynchsyndrome
AT ishidahideyuki clinicalfeaturesofbiliarytractcancerinjapaneseindividualswithlynchsyndrome
AT tanakayakohji clinicalfeaturesofbiliarytractcancerinjapaneseindividualswithlynchsyndrome